you are here:

Biocon Ltd.

BSE: 532523 | NSE: BIOCON |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE376G01013 | SECTOR: Pharmaceuticals

BSE Live

Oct 26, 15:06
333.05 11.80 (3.67%)
Volume
AVERAGE VOLUME
5-Day
306,346
10-Day
295,480
30-Day
198,126
110,864
  • Prev. Close

    321.25

  • Open Price

    323.65

  • Bid Price (Qty.)

    332.80 (120)

  • Offer Price (Qty.)

    333.10 (20)

NSE Live

Oct 26, 15:06
333.00 11.70 (3.64%)
Volume
AVERAGE VOLUME
5-Day
3,840,010
10-Day
3,223,305
30-Day
2,940,627
2,733,756
  • Prev. Close

    321.30

  • Open Price

    323.00

  • Bid Price (Qty.)

    332.85 (27)

  • Offer Price (Qty.)

    333.00 (1583)

ANNOUNCEMENTS ON Biocon

  • Oct 21, 2021 23:18 Source: BSE

    Biocon - Financial Results For The Quarter And Half Year Ended September 30, 2021.

    Pursuant to Regulation 30 and 33 of SEBI (Listing Obligation and Disclosure Requirements) 2015, we wish to inform you that the Board of Directors at its meeting held today, has considered and approved the un-audited financial results (standalone and consolidated) as per Indian Accounting Standard (Ind-AS) along with Limited Review Report for the quarter and half year ended September 30, 2021. A copy of the un-audited financial results along with the Limited Review Report is enclosed herewith.

CORPORATE ANNOUNCEMENTS

BOARD MEETING

Meeting Date : Oct 21, 2021
Remark : Quarterly Results